Trial NCT01151449

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-03135
Secondary IDs: 8561 N01CM00032 NCI-2012-03135 PHL-076

Last trial update was posted on 2017-04-11

MeSH Interventions

2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide

MeSH Conditions

Breast Neoplasms Breast Neoplasms, Male Recurrence Triple Negative Breast Neoplasms

Other Conditions

Estrogen Receptor-negative Breast Cancer HER2-negative Breast Cancer Male Breast Cancer Progesterone Receptor-negative Breast Cancer Recurrent Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Triple-negative Breast Cancer

Stopping Reasons

Administratively Complete

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID